Chris Dall | News Reporter | CIDRAP NewsJun 11, 2020Also, the NIH said researchers will begin assessing antiviral and anti-inflammatory drugs in children.
Regeneron to begin trials for COVID-19 antibody cocktail
More from COVID-19More posts in COVID-19 »
- Swedish study suggests link between long COVID and severity of illness
- Meta-analysis: Global COVID reinfection rate less than 1%, depending on variant, country, time
- Study: Kids with COVID but no symptoms play key role in household spread
- Survey identifies unmet child medical needs in first 2 US COVID pandemic waves